Paul Roesch
About Paul Roesch
Paul Roesch serves as the Sr. Director of Newborn Screening at Baebies, where he focuses on developing innovative products and services for the medical device and life science industries. With extensive experience in mass spectrometry and digital microfluidics, he empowers teams to enhance patient care.
Current Role at Baebies
Paul Roesch serves as the Sr. Director of Newborn Screening at Baebies since 2021. In this role, he focuses on developing and implementing strategies that enhance newborn screening processes. His leadership aims to empower teams and support medical professionals, ensuring that patient care remains a priority.
Previous Experience at Baebies
Prior to his current position, Paul Roesch held multiple roles at Baebies. He worked as the Director of Newborn Screening from 2020 to 2021 and as the Product Support Manager for Lab Products from 2018 to 2020. His tenure at Baebies has been marked by a commitment to exceeding customer needs through innovative product design and service.
Professional Background in Medical Device Industry
Paul Roesch has extensive experience in the medical device and life sciences sectors. He worked at PerkinElmer as a Diagnostics Technical Support Leader for nine years, where he provided technical support across the Americas. His background also includes roles at GOJO Industries and Amresco, where he contributed to production processes and quality control.
Educational Qualifications
Paul Roesch earned a Bachelor of Science degree from the University of Findlay, specializing in Environmental and Hazardous Materials Management, Health Physics, and Chemistry. This educational foundation supports his expertise in mass spectrometry and digital microfluidics, both critical to newborn screening.
Specialized Skills and Expertise
Paul Roesch possesses specialized skills in mass spectrometry and digital microfluidics. These techniques are essential for analyzing chemical substances and manipulating small fluid volumes, respectively. His expertise is particularly relevant in the context of newborn screening, where precise analysis is crucial.